Paying users zone. Data is covered by .

  • Get to Biogen Inc. for $15.99, or

  • get to whole website for at least 3 months from $49.99.



Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Biogen Inc., Consolidated Statement of Cash Flows

USD $ in thousands

12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net income
Depreciation and amortization
Acquired in-process research and development
Share-based compensation
Deferred income taxes
Contingent consideration
Accounts receivable
Due from anti-CD20 therapeutic programs
Other assets
Accrued expenses and other current liabilities
Income tax assets and liabilities
Other liabilities
Changes in operating assets and liabilities, net
Adjustments to reconcile net income to net cash flows from operating activities
Net cash flows provided by operating activities
Proceeds from sales and maturities of marketable securities
Purchases of marketable securities
Acquisition of TYSABRI rights
Contingent consideration related to Fumapharm AG acquisition
Acquired in-process research and development
Acquisitions of businesses, net of cash acquired
Purchases of property, plant and equipment
Acquisitions of intangible assets
Net cash flows used in investing activities
Purchase of treasury stock
Proceeds from (payments related to) issuance of stock for share-based compensation arrangements, net
Net distribution to noncontrolling interest
Proceeds from borrowings
Repayments of borrowings
Net cash contribution to Bioverativ, Inc.
Excess tax benefit from share-based compensation
Contingent consideration payments
Net cash flows provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of the year
Cash and cash equivalents, end of the year
Source: Biogen Inc., Annual Reports
Item Description The company
Net cash flows provided by operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Biogen Inc.'s net cash flows provided by operating activities increased from 2015 to 2016 and from 2016 to 2017.